Genmab — Juni 2022

Helge_LarsenPI-redaktør

Biotech Stocks Facing FDA Decision In July 2022 https://www.proinvestor.com/investornyt/843364/biotech-stocks-facing-fda-decision-in-july-2022

nohope

Forsigtigt spørgsmål. RMS er det der kaldes attakvis sclerose og som er det 80 % af sclerose patienter diagnosticeres med ?

ProinvestorNEWS

Aktier/middag: SAS i hopla efter norsk tilsagn - medicinal tynger C25
https://www.proinvestor.com/investornyt/843378/aktier-middag-sas-i-hopla-efter-norsk-tilsagn-medicinal-tynger-c25

nohope

Tak

ProinvestorNEWS

USA/åbning: Banker og tech sendes op i grønt marked - Nike falder
https://www.proinvestor.com/investornyt/843526/usa-abning-banker-og-tech-sendes-op-i-gront-marked-nike-falder

E_L

NEW TRIAL: A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy https://www.clinicaltrials.gov/ct2/show/NCT05435339

Bulder

so this is a new biontec collaboration drug. What do we know about targets?

Bulder

Is it hex or duo?

Solsen

I cant find anything. I belive Biontech have had some info latest.

E_L

all good questions

E_L

the only guess i can make is that it could be a hexabody, as Biointech (mistakenly?) put a reference to a hexabody in one of their presentations a while ago